These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3022498)

  • 1. Inhibition of Epstein-Barr virus infection in vitro by recombinant human interferons alpha and gamma.
    Kure S; Tada K; Wada J; Yoshie O
    Virus Res; 1986 Sep; 5(4):377-90. PubMed ID: 3022498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of human recombinant interferons on the expression of two early gene products of Epstein-Barr virus.
    Lidin B; Lamon EW
    Antiviral Res; 1992 Jan; 17(1):79-89. PubMed ID: 1371044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different kinetics of antiviral and anticellular activities between human recombinant and natural interferon-gamma arising from different receptor-binding properties.
    Gomi K; Akinaga S; Inoue A; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1986 Sep; 77(9):946-55. PubMed ID: 3095289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes.
    Swaminathan S; Huneycutt BS; Reiss CS; Kieff E
    J Virol; 1992 Aug; 66(8):5133-6. PubMed ID: 1321292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human interferons on rheumatoid arthritis B lymphocytes activated by Epstein-Barr virus.
    Lotz M; Tsoukas CD; Curd JG; Carson DA; Vaughan JH
    J Rheumatol; 1987 Feb; 14(1):42-5. PubMed ID: 3033238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic anticellular and antiviral activities of human recombinant interferon-gamma and -beta.
    Gomi K; Kimura H; Okabe M; Oka T; Morimoto M
    J Pharmacobiodyn; 1986 Nov; 9(11):871-8. PubMed ID: 3031263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
    Gomi K; Akinaga S; Oka T; Morimoto M
    Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus replication in interferon-treated cells.
    Sharp NA; Arrand JR; Clemens MJ
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2521-6. PubMed ID: 2550580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma.
    Lotz M; Tsoukas CD; Fong S; Carson DA; Vaughan JH
    Eur J Immunol; 1985 May; 15(5):520-5. PubMed ID: 2581792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Chen A; Zhao B; Kieff E; Aster JC; Wang F
    J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulation during acute infection with Epstein-Barr virus: dynamics of interferon and 2',5'-oligoadenylate synthetase activity.
    Brewster FE; Byron KS; Sullivan JL
    J Infect Dis; 1985 Jun; 151(6):1109-15. PubMed ID: 2582067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells.
    Kanamori M; Watanabe S; Honma R; Kuroda M; Imai S; Takada K; Yamamoto N; Nishiyama Y; Kawaguchi Y
    J Virol; 2004 Apr; 78(8):3984-93. PubMed ID: 15047814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic inhibition of Epstein-Barr virus: transformation of B lymphocytes by alpha and gamma interferon and by 3'-azido-3'-deoxythymidine.
    Lin JC; Zhang ZX; Chou TC; Sim I; Pagano JS
    J Infect Dis; 1989 Feb; 159(2):248-54. PubMed ID: 2536780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
    Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
    J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
    Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
    J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibitory effect of Hu-IFN-gamma on the agarose clonability of tumor-derived lymphoid cell lines.
    Torsteinsdottir S; Masucci MG; Bejarano MT; Berthold W; Klein E; Klein G
    Cell Immunol; 1985 Jan; 90(1):65-73. PubMed ID: 2981638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.